Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Carter

Showing results (211-220 of 533) with videos related to

Pageof 54
Sort By:
Journal of Communication Disorders|March 1, 2003
Similarities in weak syllable omissions between children with specific language impairment and normally developing language: a preliminary reportAllyson K Carter, LouAnn Gerken
National Cancer Institute Monograph|March 1, 1977
Experimental models and their clinical correlationsS K Carter, A Goldin
Demography|November 1, 1982
A model for inferring the voluntary and involuntary causes of residential segregationS Lieberson, D K Carter
Cancer Treatment Reviews|December 1, 1975
Cyclophosphamide in solid tumorsS K Carter, R B Livingston
Journal of the American Veterinary Medical Association|September 15, 1991
Persistent thrombocytopenia in a case of equine infectious anemiaN D Cohen, G K Carter
Cancer Treatment Reviews|June 1, 1975
The integration of chemotherapy into a combined modality approached to cancer therapy. V. Squamous cell cancer of the head and neckM A Goldsmith, S K Carter
The American Journal of Physiology|February 1, 1970
Effect of vasoactive agents on urine and electrolyte excretion in the chickenD G May, M K Carter
CA: a Cancer Journal for Clinicians|November 1, 1974
New chemotherapeutic agents--bleomycin and adriamycinS K Carter, R H Blum
Cancer|November 1, 1974
A review of chemotherapy in gastric cancerR L Comis, S K Carter
European Journal of Cancer|February 1, 1972
5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanomaS K Carter, M A Friedman
Pageof 54

Showing results (211-220 of 533) with videos related to

Sort By:
Pageof 54
Journal of Communication Disorders|March 1, 2003
Similarities in weak syllable omissions between children with specific language impairment and normally developing language: a preliminary reportAllyson K Carter, LouAnn Gerken
National Cancer Institute Monograph|March 1, 1977
Experimental models and their clinical correlationsS K Carter, A Goldin
Demography|November 1, 1982
A model for inferring the voluntary and involuntary causes of residential segregationS Lieberson, D K Carter
Cancer Treatment Reviews|December 1, 1975
Cyclophosphamide in solid tumorsS K Carter, R B Livingston
Journal of the American Veterinary Medical Association|September 15, 1991
Persistent thrombocytopenia in a case of equine infectious anemiaN D Cohen, G K Carter
Cancer Treatment Reviews|June 1, 1975
The integration of chemotherapy into a combined modality approached to cancer therapy. V. Squamous cell cancer of the head and neckM A Goldsmith, S K Carter
The American Journal of Physiology|February 1, 1970
Effect of vasoactive agents on urine and electrolyte excretion in the chickenD G May, M K Carter
CA: a Cancer Journal for Clinicians|November 1, 1974
New chemotherapeutic agents--bleomycin and adriamycinS K Carter, R H Blum
Cancer|November 1, 1974
A review of chemotherapy in gastric cancerR L Comis, S K Carter
European Journal of Cancer|February 1, 1972
5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanomaS K Carter, M A Friedman
Pageof 54